Latest Breaking News On - Cellares cell shuttle - Page 1 : comparemela.com

Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing News provided by Share this article Share this article SOUTH SAN FRANCISCO, Calif., May 5, 2021 /PRNewswire/   Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, today announced it has secured $82 million in a Series B round, bringing total funding to date to $100 million. The round was led by new investor Decheng Capital and co-led by existing investor Eclipse Ventures. Skyviews Life Science joined as a new investor, with previous investor 8VC also participating. Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing

Fabian gerlinghausSanford lorraine crossCellare early access partnership programCellares corporationUniversity of pennsylvaniaFred hutchinson cancer research centerBusiness developmentCell shuttleCellares cell shuttleCarl juneSanford lorraine cross awardCellares advisory board memberSouth san franciscoசான்ஃபோர்ட் லோரெய்ன் குறுக்குபல்கலைக்கழகம் ஆஃப் பென்சில்வேனியாஃப்ரெட் ஹட்சின்சன் புற்றுநோய் ஆராய்ச்சி மையம்